<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">urovest</journal-id><journal-title-group><journal-title xml:lang="en">Urology Herald</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник урологии</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2308-6424</issn><publisher><publisher-name>Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2308-6424-2024-12-4-5-13</article-id><article-id custom-type="elpub" pub-id-type="custom">urovest-907</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>Transurethral balloon dilation safety and efficacy in patients with recurrent bladder neck contracture after transurethral interventions</article-title><trans-title-group xml:lang="ru"><trans-title>Безопасность и эффективность трансуретральной баллонной дилатации у пациентов с рецидивирующей контрактурой шейки мочевого пузыря после трансуретральной хирургии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6212-3693</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аббосов</surname><given-names>Ш. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Abbosov</surname><given-names>Sh. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аббосов Шухрат Анварович — канд. мед. наук.</p><p>Ташкент</p></bio><bio xml:lang="en"><p>Shukhrat A. Abbosov — Cand.Sc.(Med).</p><p>Tashkent</p></bio><email xlink:type="simple">shuhrat0770@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9271-0808</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шомаруфов</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Shomarufov</surname><given-names>A. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шомаруфов Азизбек Баходирович — канд. мед. наук.</p><p>Ташкент</p></bio><bio xml:lang="en"><p>Azizbek B. Shomarufov - Cand.Sc.(Med).</p><p>Tashkent</p></bio><email xlink:type="simple">doctor.shomarufov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-1729-9429</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аминова</surname><given-names>Д. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Aminova</surname><given-names>D. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аминова Дилафруз Рустамовна.</p><p>Ташкент</p></bio><bio xml:lang="en"><p>Dilafruz R. Aminova.</p><p>Tashkent</p></bio><email xlink:type="simple">dilafruzaminovaa@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ташкентская медицинская академия; Республиканский специализированный научно-практический медицинский центр урологии</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>Tashkent Medical Academy; Republican Specialized Scientific-Practical Medical Center of Urology</institution><country>Uzbekistan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Ташкентская медицинская академия</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>Tashkent Medical Academy</institution><country>Uzbekistan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>04</day><month>09</month><year>2024</year></pub-date><volume>12</volume><issue>4</issue><fpage>5</fpage><lpage>13</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Abbosov S.A., Shomarufov A.B., Aminova D.R., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Аббосов Ш.А., Шомаруфов А.Б., Аминова Д.Р.</copyright-holder><copyright-holder xml:lang="en">Abbosov S.A., Shomarufov A.B., Aminova D.R.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.urovest.ru/jour/article/view/907">https://www.urovest.ru/jour/article/view/907</self-uri><abstract><sec><title>Introduction</title><p>Introduction. Currently, urologists are divided on which method is most effective for treating bladder neck contracture (BNC) after surgery: transurethral resection (TUR) or incision.</p></sec><sec><title>Objective</title><p>Objective. The study aimed to assess the balloon dilation safety and success in patients with recurrent bladder neck contracture (BNC) after endoscopic surgery for benign prostatic hyperplasia (BPH).</p></sec><sec><title>Materials &amp; Methods</title><p>Materials &amp; Methods. This study involved 110 patients with recurrent BNC after transurethral interventions for BPH. All patients underwent TUR of the bladder neck and were divided into 2 groups: group A (n = 45) included men who, after TUR, additionally underwent repeated balloon dilation, while the control group B (n = 65) included men who were treated with alpha-blockers alone.</p></sec><sec><title>Results</title><p>Results. In 9 months after TUR and 3 months after the fourth balloon dilation procedure in group A, the mean international prostate symptom score (IPSS) decreased from 20.1 ± 8.4 to 17.2 ± 7.4, and the IPSS-quality of life (QoL) was 4.2 ± 1.2 (p &gt; 0.05). In group B, they were 21.7 ± 7.7 and 4.7 ± 1.1 (p &gt; 0.05), respectively. Additionally, the mean flow rate in group A was 13.2 ± 5.4 ml/s, while in group B, it was 8.7 ± 4.9 ml/s (p &lt; 0.05). There was a significant decrease in the post-void residual urine volume (PVR) from 76.2 ± 96.1 ml to 37.6 ± 55.1 ml in group A, whereas, in group B, it increased from 63.0 ± 36.9 ml to 79.4 ± 71.6 ml (p &gt; 0.05). Also, 28.0% of patients of group B, and 13.3% of patients of group A underwent repeated TUR of the bladder neck in 9 months follow-up period (p &lt; 0.05).</p></sec><sec><title>Conclusion</title><p>Conclusion. Balloon dilation procedure is a relatively safe less invasive procedure and can reduce the BNC recurrence rate and consequently the rate of repeated transurethral interventions.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Введение</title><p>Введение. В настоящее время урологи расходятся во мнении, какой метод лечения контрактуры шейки мочевого пузыря (КШМП) является наиболее эффективным: трансуретральная резекция (ТУР) или разрез.</p></sec><sec><title>Цель исследования</title><p>Цель исследования. Оценить безопасность и эффективность баллонной дилатации у пациентов с рецидивирующей контрактурой шейки мочевого пузыря после эндоскопического лечения доброкачественной гиперплазии простаты (ДГП).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование включено 110 пациентов с рецидивом КШМП после трансуретральных вмешательств по поводу ДГП. Все пациенты перенесли трансуретральную резекцию (ТУР) шейки мочевого пузыря и были разделены на 2 группы: в группу А (n = 45) вошли мужчины, которым после ТУР дополнительно проводилась повторная баллонная дилатация, а в контрольную группу В (n = 65) — мужчины, получавшие только альфа-блокаторы.</p></sec><sec><title>Результаты</title><p>Результаты. Через 9 месяцев после ТУР и через 3 месяца после четвертой процедуры баллонной дилатации в группе А средний балл по международной шкале простатических симптомов (IPSS) снизился с 20,1 ± 8,4 до 17,2 ± 7,4, а показатель качества жизни (QoL) по шкале составил 4,2 ± 1,2 (p &gt; 0,05). В группе В эти показатели составили 21,7 ± 7,7 и 4,7 ± 1,1 (p &gt; 0,05), соответственно. Кроме того, средняя скорость потока мочи в группе А составила 13,2 ± 5,4 мл/с, а в группе В — 8,7 ± 4,9 мл/с (p &lt; 0,05). Наблюдалось значительное снижение объёма остаточной мочи после мочеиспускания с 76,2 ± 96,1 мл до 37,6 ± 55,1 мл в группе А, в то время как в группе В он увеличился с 63,0 ± 36,9 мл до 79,4 ± 71,6 мл (p &gt; 0,05). Кроме того, 28,0% пациентов группы В и 13,3% пациентов группы А подверглись повторной ТУР шейки мочевого пузыря через 9 месяцев наблюдения (p &lt; 0,05).</p></sec><sec><title>Заключение</title><p>Заключение. Процедура баллонной дилатации является относительно безопасной и менее инвазивной процедурой и может снизить частоту рецидивов КШМП, а следовательно, и частоту повторных трансуретральных вмешательств.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>трансректальное ультразвуковое исследование</kwd><kwd>доброкачественная гиперплазия предстательной железы</kwd><kwd>баллонная дилатация</kwd><kwd>контрактура шейки мочевого пузыря</kwd></kwd-group><kwd-group xml:lang="en"><kwd>bladder neck contracture</kwd><kwd>benign prostatic hyperplasia</kwd><kwd>balloon dilation</kwd><kwd>transrectal ultrasound</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Transurethral resection of the prostate (TURP) and endoscopic enucleation is currently considered the most effective [1 – 6], mastered, and available standards of surgical correction of bladder outlet obstruction [<xref ref-type="bibr" rid="cit7">7</xref>]. The operation has been used in clinical practice for more than 50 years and is recognized as an effective, relatively safe method of treating patients with benign prostatic hyperplasia (BPH) of medium size and is accompanied by a small number of such short term postoperative complications as minor bleeding (is observed in approximately 1.7% to 8.2% of cases), and TUR syndrome (occurs in up to 1.1% of cases) and a short length of hospital stay [<xref ref-type="bibr" rid="cit4">4</xref>][<xref ref-type="bibr" rid="cit8">8</xref>]. Nevertheless, the long-term sclerotic changes in the bladder neck that occur after endoscopic procedures on the prostate require repeated surgical interventions, which significantly reduce the quality of life of patients and negatively affect the state of the male genitourinary system.</p><p>It should be noted that with TURP performed in a small volume of BPH, complications occur in 15% of cases and include bleeding, urethral stricture (which is detected in 2.2 – 9.8% of cases), and subsequent sclerosis (ranging from 0.3% to 9.1% of cases) [9 – 11]. One of the reasons for the fibrosis the formation is the extended resection of tissues in the bladder neck, which can be the cause of narrowing or deformity [<xref ref-type="bibr" rid="cit12">12</xref>].</p><p>The treatment of sclerosis is a difficult task [<xref ref-type="bibr" rid="cit13">13</xref>], even for experienced urologists, as often several interventions have to be performed to correct the bladder outlet obstruction [<xref ref-type="bibr" rid="cit14">14</xref>]. As a rule, the following endoscopic methods are used: dilation, image-guided urethrotomy, and bladder neck resection. After such interventions, urinary incontinence is common, which worsens the quality of life of patients [<xref ref-type="bibr" rid="cit15">15</xref>][<xref ref-type="bibr" rid="cit16">16</xref>].</p><p>Currently, there is no consensus among urologists regarding which method is advisable for postoperative stricture of the posterior urethra / bladder neck (bladder neck contracture — BNC): TUR or incision. Therefore, we aimed to assess the results of transurethral balloon dilation of the bladder neck in patients with recurrent BNC after endoscopic surgeries for BPH.</p></sec><sec><title>Materials and Methods</title><p>Study Design. This prospective non-randomized multicentre study was approved by the Institutional Local Ethical Committees of Medical Research and Educational Centre of Lomonosov Moscow State University (MREC, Moscow, Russia) (№ 1/21 from 25.01.2019) and the Republican Specialized Scientific and Practical Medical Centre of Urology (RSSPMCU, Tashkent, Uzbekistan) (№ 6 from 01.08.2021) which was conducted following the Declaration of Helsinki and the Good Clinical Practice guidelines. All patients signed an appropriate informed consent.</p><p>Patients. In total 173 patients underwent TURP and laser enucleation underwent TUR underwent TUR of the bladder neck using electro- (bipolar) and laser energy during the period from April 2019 to August 2022 at the MREC and RSSPMCU.</p><p>The criteria for the inclusion of patients in the study were the presence of BNC formed after TURP and endoscopic enucleation of the BPH.</p><p>35 patients who underwent surgeries for malignant neoplasms of the prostate were excluded from the study. 13 patients were excluded because of post-traumatic urethral strictures and 15 patients were excluded because of post-inflammatory urethral strictures. As a result, 110 patients were included in our study. After the intervention, the patients were randomized into two groups: group A (n = 45) included men who additionally underwent transurethral balloon dilation after TUR of the bladder neck, while control group B (n = 65) included men who received conservative therapy alone with alpha-blockers (tamsulosin 0.4 mg o.d.).</p><p>All patients, in addition to routine clinical and laboratory studies, underwent uroflowmetry before surgery, and the volume of residual urine (PVR) was also measured. Transrectal ultrasonography (TRUS) of the prostate was performed. Narrowing (sclerosis) of the bladder neck was confirmed by urethrocystoscopy (Fig. 1).</p><fig id="fig-1"><caption><p>Figure 1. Cystoscopic view of bladder neck contracture</p></caption><graphic xlink:href="urovest-12-4-g001.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/urovest/2024/4/sWlTr685XuEH7GMtMBTqRkyyeY82MZY5U79pRQr7.jpeg</uri></graphic></fig><p>Balloon dilation technique. To assess the condition of the bladder neck before balloon dilation, prostate TRUS was performed, and the condition of the prostate was assessed by visualizing it in a longitudinal and cross-section. For the transrectal ultrasound diagnostic system, EPIQ 7 (Koninklijke Philips N.V. — Philips Medical Systems Nederland B.V., Heerlen, The Netherlands) with an intracavitary probe (4 – 10 MHz) was utilized. The length of the bed of the removed BPH, the anteroposterior dimension in the widest part, the bilateral dimension in the widest part, the volume of the defect, and the anteroposterior dimension of the bladder neck were measured (Fig. 2).</p><fig id="fig-2"><caption><p>Figure 2. TRUS picture of the prostate and bed of the removed BPH: A — longitudinal section; B — cross-section</p></caption><graphic xlink:href="urovest-12-4-g002.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/urovest/2024/4/wL4Kjf3DDBlZ5Ymh8pqZflsBKSD52zkuyiEuOdk7.jpeg</uri></graphic></fig><p>After the introduction of Cathejell® with Lidocaine 12.5 gr. anesthetic gel into the urethra, a balloon-type urethral catheter — 3-way Dufour Rusch® SoftSimplastic (Teleflex Medical Europe, Ltd., Dublin, Ireland) with an increased capacity was inserted through the urethra into the lumen of the bladder. The best approach, in our opinion, for this procedure is an 18 Fr balloon catheter, the diameter of which allows it to pass through the narrowed part of the urethra and the elasticity of which is sufficient to dilate the fibrotic ring of the bladder neck. Balloon dilation was performed with a bladder volume of at least 150 ml.</p><p>Under TRUS control, the balloon of the urethral catheter was placed into the lumen of the bladder neck so that the widest part of the balloon was localized around the fibrotic ring of the bladder neck and inflated to a size slightly larger than the diameter of the bed of the removed BPH so that the walls of the balloon exerted pressure on the fibrotic ring. The balloon was left in this position for 5 minutes, during which, due to the property of elasticity, the balloon tended to take the shape characteristic of the inflated state and eliminate the compression, due to which gentle elastic stretching and tearing of the fibrotic ring of the bladder neck occurred. Next, a similar manipulation was performed by moving the balloon to the bed of the removed BPH (Fig. 2). Then the balloon was completely deflated and removed from the bladder cavity. The approximate procedure duration was 15 – 20 minutes.</p><fig id="fig-3"><caption><p>Figure 3. TRUS guided balloon dilation procedure (arrow — balloon of the catheter located around the bladder neck fibrotic ring): A — after the inflation of the balloon (5 ml); B — after the 5-minute exposition</p></caption><graphic xlink:href="urovest-12-4-g003.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/urovest/2024/4/NjRp1s0yiWqVHasWxUpif5SiOkKokTNd54hFt1fh.jpeg</uri></graphic></fig><p>To evaluate the results of the performed procedure, the measurements of the length of the removed BPH bed, the anteroposterior size in the widest part, the bilateral size in the widest part, the anteroposterior size, and the volume of the bladder neck defect were repeated. The results of both measurements reflect the state of the neck before and after the manipulation, that is, they visualize the dilating effect of the procedure. This study allowed us to assess the individual dynamics of the functional state of the bladder neck according to the above indicators. After the completion of the manipulation, uroflowmetry was performed to control the urodynamic status of the patient.</p><p>Recurrence of BNC was defined as decreased urinary flow rate, incomplete bladder emptying, increased PVR, the obstructive pattern on the uroflow study, increased IPSS-score.</p><p>Balloon dilation was performed in several sessions until the desired effect was obtained, and the results of stretching the bladder neck were consolidated. The patient underwent repeated balloon dilation interventions in 1, 2, 3, and 6 months after TUR of the bladder neck.</p><p>Statistical Analysis. Statistical data analyzed in MS Excel 2016 Microsoft Office Excel 365 (Microsoft Corp., Redmond, WA, USA) and IBM SPSS© Statistics 20.0 (SPSS: An IBM Company, IBM SPSS Corp., Armonk, NY, USA) statistical packages. The analysis of the obtained values distribution normality was carried out according to the one-sample Kolmogorov-Smirnov Z criterion. When a distribution is normal, the mean values for the groups are presented as a sample mean value and standard deviation — M (S), and when it differs from normal, as a median with 25 – 75% quartiles. The significance of differences between groups is calculated using Students (t) tests for means, Mann-Whitney, and Wilcoxon for medians and ranks; differences are considered significant at p &lt; 0.05.</p></sec><sec><title>Results</title><p>Patients and Treatment. In total 110 patients were randomly divided into group A (n = 45) men who underwent balloon dilation after TUR, and control group B (n = 65) men who received conservative therapy only.</p><p>The main baseline clinical and anamnestic characteristics of the patients are shown in table 1.</p><table-wrap id="table-1"><caption><p>Table 1. Baseline clinical parameters of patients</p></caption><table><tbody><tr><td>Groups</td><td>Mean age, years</td><td>Body mass index, kg/m²</td><td>Prostate volume (before BPH surgery), cm³</td><td>Urinary tract infections, n (%)</td><td>Number of prior interventions, mean ± SD</td><td>Type 2 diabetes mellitus, n (%)</td><td>Ischemic heart disease, n (%)</td></tr><tr><td>Group А&#13;
(n = 45)</td><td>65.7 ± 11.6</td><td>27.3 ± 3.9</td><td>40.7 ± 9.3</td><td>28 (62.2%)</td><td>2.2 ± 1.1</td><td>9 (20%)</td><td>16 (35.5%)</td></tr><tr><td>Group B&#13;
(n = 65)</td><td>63.7 ± 12.8</td><td>25.6 ± 7.5</td><td>42.4 ± 10.9</td><td>43 (66%)</td><td>2.7 ± 2.4</td><td>14 (21.5%)</td><td>28 (43%)</td></tr><tr><td>Р</td><td>&gt; 0.05</td><td>&gt; 0.05</td><td>&gt; 0.05</td><td>&gt; 0.05</td><td>&gt; 0.05</td><td>&gt; 0.05</td><td>&gt; 0.05</td></tr></tbody></table></table-wrap><p>Clinical Outcome. In 1 month after the 1st balloon dilation procedure, the main parameters (uroflowmetry, PVR, IPSS, IPSS-QoL) of the patients of group A improved significantly (p &lt; 0.05 for all). There was a statistically significant difference between groups after treatment in all parameters, except for IPSS (Tabl. 2), i.e. in patients of group A, these parameters were significantly better.</p><table-wrap id="table-2"><caption><p>Table 2. Dynamics of some parameters in the groups after balloon dilation of the bladder neck</p><p>Note. * Check-up 1 – 2 months after TUR and 1 month after the 1st balloon dilation procedure; Check-up 2 – 3 months after TUR and 1 month after the 2ed balloon dilation procedure; Check-up 3 – 4 months after TUR and 1 month after the 3rd balloon dilation procedure; Check-up 4 – 9 months after TUR and 3 months after the 4th balloon dilation procedure; ** — p &lt; 0.05, between Group A and B</p></caption><table><tbody><tr><td>Groups</td><td>Indicators</td><td>Before</td><td>Check-up 1*</td><td>Check-up 2*</td><td>Check-up 3*</td><td>Check-up 4*</td></tr><tr><td>Group A&#13;
(n = 45)</td><td>IPSS</td><td>20.1 ± 8.4</td><td>13.4 ± 5.8**</td><td>14.5 ± 6.2</td><td>13.7 ± 7.9**</td><td>17.2 ± 7.4**</td></tr><tr><td>IPSS-QoL</td><td>4.4 ± 1.0</td><td>2.7 ± 0.8**</td><td>3.4 ± 1.2**</td><td>3.4 ± 1.3**</td><td>4.2 ± 1.2**</td></tr><tr><td>Q max (ml/s)</td><td>7.8 ± 2.9</td><td>14.6 ± 4.4</td><td>12.1 ± 3.1</td><td>10.1 ± 3.1</td><td>13.2 ± 5.4**</td></tr><tr><td>PVR (ml)</td><td>76.2 ± 96.1</td><td>15.8 ± 12.7**</td><td>16.7 ± 11.5**</td><td>31.3 ± 36.9*</td><td>37.6 ± 55.1**</td></tr><tr><td>Group B&#13;
(n = 65)</td><td>IPSS</td><td>18.6 ± 6.7</td><td>16.7 ± 6.1</td><td>16.8 ± 6.5</td><td>19.0 ± 8.4</td><td>21.7 ± 7.7</td></tr><tr><td>IPSS-QoL</td><td>4.2 ± 0.9</td><td>3.7 ± 0.7</td><td>4.4 ± 1.1</td><td>4.3 ± 1.1</td><td>4.7 ± 1.1</td></tr><tr><td>Q max (ml/s)</td><td>8.2 ± 4.3</td><td>13.7 ± 6.1</td><td>10.7 ± 4.9</td><td>8.9 ± 4.5</td><td>8.7 ± 4.9</td></tr><tr><td>PVR (ml)</td><td>63.0 ± 36.9</td><td>33.7 ± 22.6</td><td>56.7 ± 84.5</td><td>65.2 ± 46.7</td><td>79.4 ± 71.6</td></tr></tbody></table></table-wrap><p>However, a slight worsening of the studied parameters was observed in group A beginning from 3 months after the TUR and this tendency saved till the end of the follow-up. But in comparison with the parameters of patient of the group B given worsening was not so significant. Significant deterioration in 3 months after TURP developed in 4 (8.8%) patients in group A, whereas in group B, deterioration was observed in 12 (18,5%) patients (p &lt; 0.05). This indicator was 20% (9 patients) and 35% (23 patients) in groups A and B after 9 months, respectively (p &lt; 0.05).</p><p>In 9 months after TURP of the bladder neck and 3 months after the 4th balloon dilation, the average maximum urine flow rate in group A was 13.2 ± 5.4 ml/s, while in group B this parameter was 8.7 ± 4.9 ml/s. Also, in group A, a significant decrease in the PVR was revealed — from 76.2 ± 96.10 to 37.6 ± 55.1 ml, and in group B this indicator decreased from 63.0 ± 36.9 to 79.4 ± 71.6 ml (Tabl. 2).</p><p>During the follow-up period, recurrence of BNC developed in 27 patients (24.5%) of both groups. All of them underwent repeated TUR of the bladder neck. In 8 patients (7 from group B, 1 from group A) recurrence was observed in 3 months after TUR. In 12 patients (9 from group B, 3 from group A) recurrence developed after 6 months, whereas in 7 patients (5 from group B, 2 from group A) BNC recurred after 9 months. The main parameters of the patients with BNC recurrence are given in table 3.</p><table-wrap id="table-3"><caption><p>Table 3. Parameters in the groups after balloon dilation of the bladder neck, who had a recurrence</p></caption><table><tbody><tr><td>Groups</td><td>Rate (%)</td><td>IPSS</td><td>IPSS-QoL</td><td>Q max (ml/s)</td><td>PVR (ml)</td></tr><tr><td>Group A (n = 45)</td><td>6 (13.3%)</td><td>31.33 + 1.63</td><td>5.33 + 1.21</td><td>2.96 + 0.61</td><td>169.17 + 42.24</td></tr><tr><td>Group B (n = 75)</td><td>21 (32.3%)</td><td>29.89 + 0.61</td><td>5.14+0.15</td><td>3.35 + 0.17</td><td>187.38 + 27.69</td></tr><tr><td>P</td><td> </td><td>&gt; 0.05</td><td>&gt;0.05</td><td>&gt; 0.05</td><td>&gt; 0.05</td></tr></tbody></table></table-wrap><p>Adverse Events and Complication Rates. Balloon dilation procedures were accompanied by a less amount of light to moderate complications. Acute urinary retention developed only in 1 (2.2%) case, which was resolved with indwelling catheterization for 48 hours. In 2 (4.4%) patients acute orchiepididymitis was observed and treated successfully with antibacterial drugs. In 14 (31.1%) men in group A, haematuria was determined, which did not require the use of hemostatic drugs and was not accompanied by a decrease in haemoglobin in the peripheral blood, in 4 (8.8%) patients’ short-term urethrorrhagia occurred which resolved without additional therapy. Dysuria was observed in 8 (17,8%) patients, which resolved without treatment. There were no severe surgical complications in group A according to the Clavien-Dindo scoring system that required repeated intervention during the 90-day postoperative period.</p></sec><sec><title>Discussion</title><p>Despite the fact that, in recent years, new endoscopic methods of treatment of patients with BPH have been developed and introduced into practice, including bipolar resection (B-TURP) and laser enucleation, the complications’ rate after these surgical interventions remains quite high, including the urethral strictures (2.2 – 9.8%) and BNC (0.3 – 9.2%) [<xref ref-type="bibr" rid="cit15">15</xref>]. Contracture of the bladder neck significantly worsens the long-term results of TURP and the quality of life of patients, who often undergo repeated and painful surgical interventions without obtaining the desired result. Therefore, the treatment of this category of patients is a serious clinical problem, which is reflected in the fact that various methods of treatment are proposed, such as deep lateral incisions of the urethral wall using a cold knife or laser, bipolar vaporization of the bladder neck, an incision with an intravesical injection of mitomycin C and T-plasty, and finally, balloon dilation and reconstructive surgery [<xref ref-type="bibr" rid="cit17">17</xref>]. However, all of these methods of treatment are associated with a significant frequency of relapses, and urologists continue to search for the best method, preferably minimally invasive, to eliminate postoperative BNC. In this light, a promising direction is the application of the balloon dilation technique, which is successfully used in practice as an alternative method of treating urethral strictures. To our knowledge, we are the first contributors to the evidence for this method application.</p><p>It is believed that sclerosis usually occurs after resections performed on the small prostate (&lt; 30 g) and that such sclerosis is a consequence of tissue ischemia [<xref ref-type="bibr" rid="cit9">9</xref>][<xref ref-type="bibr" rid="cit15">15</xref>]. Therefore, the indications for performing TURP in cases of small prostate size should be treated very cautiously. In our study, the mean prostate size was also small (41,5 ± 9,3 g).</p><p>Steenkamp et al. studied the results of using dilation and internal urethrotomy as a treatment for postoperative urethral strictures. The authors did not find a significant difference in the effectiveness of the methods used; however, they emphasized that the procedures are less effective with an increase in the length of the stricture and recommend dilation or internal optical urethrotomy for strictures no more than 2 cm in length. In this observation, the recurrence rate 12 months after the intervention was approximately 40% in patients with urethral strictures less than 2 cm in length and 80% in patients with a length of 4 cm [<xref ref-type="bibr" rid="cit18">18</xref>]. According to our results, the recurrence rate of BNC was 24,5% (27 out of 110) during 9 months follow-up.</p><p>Transurethral balloon dilation is easy to perform and less invasive than cold knife incision, and the advantage of balloon dilation is the lower risk of urethral injury. The most frequent complications, which can occur in up to 20% of cases after urethrotomy, are perineal hematomas and bleeding from the urethra, which requires additional interventions [<xref ref-type="bibr" rid="cit18">18</xref>][<xref ref-type="bibr" rid="cit19">19</xref>]. It is also should be noted that urinary incontinence is observed in 75% of cases [<xref ref-type="bibr" rid="cit17">17</xref>]. No cases of urinary incontinence and perineal hematomas were revealed during our study.</p><p>The most expedient, easily feasible, and affordable way of eliminating postoperative bladder outlet obstruction is the use of a special catheter with a balloon that allows an increase in the lumen of the urethra [<xref ref-type="bibr" rid="cit20">20</xref>]. However, the conditions for using this method in the treatment of patients with BNC are the presence of a preserved lumen and the absence of extended urethral strictures. Therefore, when using this method, before the operation, all patients undergo urethrography and urethroscopy to determine the state of the urethra and bladder and the possibility of using balloon dilation. Dilation is usually fast, gives immediate results, and is technically relatively easy to manipulate. It should be noted that dilation involves sequential stretching rather than rupture of the stricture tissue.</p><p>There are a lot of reports dedicated to endoscopic balloon dilation of bladder neck around vesicourethral anastomosis after radical prostatectomy [<xref ref-type="bibr" rid="cit21">21</xref>]. Park et al. reported about 93% of success in 24 patients during at least 12 months [<xref ref-type="bibr" rid="cit22">22</xref>]. Transurethral balloon dilation also was performed by Ramchandani et al. in patients with postoperative stricture of the prostatic urethra after radical prostatectomy and was successful in 59% (mean, 31.5 months 7 years to 12 months) of cases; the rest of the patients underwent transurethral dissection of the bladder neck. Later, however, these men required a redo of balloon dilation. The author noted that urinary incontinence was found only in one patient who underwent incision of the bladder neck, and no case of incontinence was found in those who underwent balloon dilation [<xref ref-type="bibr" rid="cit23">23</xref>]. According to our data, the treatment success rate was 87% during 9-month period and no cases of urinary incontinence were observed.</p><p>However, Ramchandani used a “low” pressure cylinder. Ishii used a high-pressure urethral balloon catheter (up to 30 atm) to treat patients with postoperative strictures, which provided a sufficient increase in its volume and led to dilation of the narrowing. It is not clear at this time whether the higher pressure in the balloon is a positive factor, and the expansion is more efficient than using a “regular” balloon. However, on the positive side, forces are applied radially to expand the stricture while avoiding the potentially traumatic moments associated with sequential rigid dilation. The use of this method made it possible to achieve positive results in 80% of cases [<xref ref-type="bibr" rid="cit24">24</xref>]. We also used a high-pressure urethral catheter (up to 4.9 atm), which made it possible to overcome the resistance of the scar tissue of the bladder neck.</p><p>Gelman et al. reported that they applied dilation using a rigid cystoscope, and the position of the balloon was visually monitored. The authors believe that because the procedure is performed with direct imaging, it is more controllable than using wires and avoids false path formation. However, the intervention requires general or spinal anesthesia, and after surgery, there is a need for hospitalization of the patient [<xref ref-type="bibr" rid="cit25">25</xref>]. The balloon dilation technique we proposed can be performed under TRUS guidance using local anesthetics on an outpatient basis.</p><p>Therefore, Vyas et al. retrospectively studied the results of balloon dilation performed in patients with urethral strictures after endoscopic and traditional operations. Patients with stricture lengths less than 1.5 cm were treated under X-ray control. A balloon catheter (Cook Urological, Spencer, Indiana) was inserted into the urethra via a metal guide and pressurized in the balloon until the waist disappeared. It should be noted that we also focused on balloon deformation; however, we performed dilation in two areas, while the abovementioned authors used balloon dilation in one position. After the intervention, the bladder was drained using a urethral catheter, as in our case. The stricture was eliminated in 68.3% of patients [<xref ref-type="bibr" rid="cit26">26</xref>].</p><p>Xie et al. used balloon dilation of urethral strictures under ultrasonographic control. The operation was performed successfully in all patients without any major complications. The urethral catheter was removed 3 – 4 weeks after surgery. However, the method was used in the treatment of 5 patients with urethral strictures; nevertheless, the authors achieved good results, and the effectiveness of the operation was assessed using urethrocystoscopy [<xref ref-type="bibr" rid="cit27">27</xref>]. We also used ultrasonography for balloon dilation, whereby we measured the length of the bed of the removed prostate, the anteroposterior dimension in the widest part, the bilateral dimension in the widest part, the volume of the defect, and the anteroposterior dimension of the bladder neck. After dilation, the effectiveness of the manipulation was assessed by the comparison method.</p><p>Our study has certain limitations like the small size of the sample with patients who underwent balloon dilation and the short follow-up period. Nevertheless, the findings are statistically significant, which suggests that they can be extrapolated to the general sample of patients with BNC. Balloon dilation is a promising less invasive procedure that can be applied on an outpatient basis. Of course, further large-scale and well-organized studies are needed to confirm or reject the clinical value of this treatment method.</p></sec><sec><title>Conclusion</title></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Xiang P, Guan D, Du Z, Hao Y, Yan W, Wang Y, Liu Y, Liu D, Ping H. Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. Eur Radiol. 2021;31(7):4929-4946. DOI: 10.1007/s00330-020-07663-2</mixed-citation><mixed-citation xml:lang="en">Xiang P, Guan D, Du Z, Hao Y, Yan W, Wang Y, Liu Y, Liu D, Ping H. Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. Eur Radiol. 2021;31(7):4929-4946. DOI: 10.1007/s00330-020-07663-2</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Frendl DM, Chen YW, Chang DC, Kim MM. A Claims Based Assessment of Reoperation and Acute Urinary Retention after Ambulatory Transurethral Surgery for Benign Prostatic Hyperplasia. J Urol. 2021;205(2):532-538. DOI: 10.1097/JU.0000000000001390</mixed-citation><mixed-citation xml:lang="en">Frendl DM, Chen YW, Chang DC, Kim MM. A Claims Based Assessment of Reoperation and Acute Urinary Retention after Ambulatory Transurethral Surgery for Benign Prostatic Hyperplasia. J Urol. 2021;205(2):532-538. DOI: 10.1097/JU.0000000000001390</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Arcaniolo D, Manfredi C, Veccia A, Herrmann TRW, Lima E, Mirone V, Fusco F, Fiori C, Antonelli A, Rassweiler J, Liatsikos E, Porpiglia F, De Sio M, Autorino R; EAU Section of Uro-Technology (ESUT) Research Group. Bipolar endoscopic enucleation versus bipolar transurethral resection of the prostate: an ESUT systematic review and cumulative analysis. World J Urol. 2020;38(5):1177-1186. DOI: 10.1007/s00345-019-02890-9</mixed-citation><mixed-citation xml:lang="en">Arcaniolo D, Manfredi C, Veccia A, Herrmann TRW, Lima E, Mirone V, Fusco F, Fiori C, Antonelli A, Rassweiler J, Liatsikos E, Porpiglia F, De Sio M, Autorino R; EAU Section of Uro-Technology (ESUT) Research Group. Bipolar endoscopic enucleation versus bipolar transurethral resection of the prostate: an ESUT systematic review and cumulative analysis. World J Urol. 2020;38(5):1177-1186. DOI: 10.1007/s00345-019-02890-9</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sun F, Sun X, Shi Q, Zhai Y. Transurethral procedures in the treatment of benign prostatic hyperplasia: A systematic review and meta-analysis of effectiveness and complications. Medicine (Baltimore). 2018;97(51):e13360. DOI: 10.1097/MD.0000000000013360</mixed-citation><mixed-citation xml:lang="en">Sun F, Sun X, Shi Q, Zhai Y. Transurethral procedures in the treatment of benign prostatic hyperplasia: A systematic review and meta-analysis of effectiveness and complications. Medicine (Baltimore). 2018;97(51):e13360. DOI: 10.1097/MD.0000000000013360</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Fu C, Wang J, Wu P, Chen X, Hou H, Song X, Cheng W, Wang J, Liu M. Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser. J Vis Exp. 2020;(159). DOI: 10.3791/60532</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Fu C, Wang J, Wu P, Chen X, Hou H, Song X, Cheng W, Wang J, Liu M. Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser. J Vis Exp. 2020;(159). DOI: 10.3791/60532</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Enikeev D, Rapoport L, Gazimiev M, Allenov S, Inoyatov J, Taratkin M, Laukhtina E, Sung JM, Okhunov Z, Glybochko P. Monopolar enucleation versus transurethral resection of the prostate for small- and mediumsized (&lt; 80 cc) benign prostate hyperplasia: a prospective analysis. World J Urol. 2020;38(1):167-173. DOI: 10.1007/s00345-019-02757-z</mixed-citation><mixed-citation xml:lang="en">Enikeev D, Rapoport L, Gazimiev M, Allenov S, Inoyatov J, Taratkin M, Laukhtina E, Sung JM, Okhunov Z, Glybochko P. Monopolar enucleation versus transurethral resection of the prostate for small- and mediumsized (&lt; 80 cc) benign prostate hyperplasia: a prospective analysis. World J Urol. 2020;38(1):167-173. DOI: 10.1007/s00345-019-02757-z</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Reale G, Marchioni M, Altieri V, Greco F, De Nunzio C, Destefanis P, Ricciardulli S, Bergamaschi F, Fasolis G, Varvello F, Voce S, Palmieri F, Divan C, Malossini G, Oriti R, Tuccio A, Ruggera L, Tubaro A, Delicato G, Laganà A, Dadone C, De Rienzo G, Ditonno A, Frattini A, Pucci L, Carrino M, Montefiore F, Germani S, Miano R, Schips L, Rabito S, Ferrari G, Cindolo L. Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses. Minerva Urol Nefrol. 2020;72(5):622-628. DOI: 10.23736/S0393-2249.20.03597-3</mixed-citation><mixed-citation xml:lang="en">Reale G, Marchioni M, Altieri V, Greco F, De Nunzio C, Destefanis P, Ricciardulli S, Bergamaschi F, Fasolis G, Varvello F, Voce S, Palmieri F, Divan C, Malossini G, Oriti R, Tuccio A, Ruggera L, Tubaro A, Delicato G, Laganà A, Dadone C, De Rienzo G, Ditonno A, Frattini A, Pucci L, Carrino M, Montefiore F, Germani S, Miano R, Schips L, Rabito S, Ferrari G, Cindolo L. Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses. Minerva Urol Nefrol. 2020;72(5):622-628. DOI: 10.23736/S0393-2249.20.03597-3</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ibrahimi A, Ziani I, El Boukili El Makhoukhi Z, El Sayegh H, Benslimane L, Nouini Y. Transurethral resection syndrome: A rare complication of intraperitoneal bladder perforation during transurethral resection of bladder tumor. Urol Case Rep. 2020;34:101465. DOI: 10.1016/j.eucr.2020.101465</mixed-citation><mixed-citation xml:lang="en">Ibrahimi A, Ziani I, El Boukili El Makhoukhi Z, El Sayegh H, Benslimane L, Nouini Y. Transurethral resection syndrome: A rare complication of intraperitoneal bladder perforation during transurethral resection of bladder tumor. Urol Case Rep. 2020;34:101465. DOI: 10.1016/j.eucr.2020.101465</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006;50(5):969-979; discussion 980. DOI: 10.1016/j.eururo.2005.12.042</mixed-citation><mixed-citation xml:lang="en">Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006;50(5):969-979; discussion 980. DOI: 10.1016/j.eururo.2005.12.042</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384-397. DOI: 10.1016/j.eururo.2010.06.005</mixed-citation><mixed-citation xml:lang="en">Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384-397. DOI: 10.1016/j.eururo.2010.06.005</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Grechenkov A, Sukhanov R, Bezrukov E, Butnaru D, Barbagli G, Vasyutin I, Tivtikyan A, Rapoport L, Alyaev Y, Glybochko P. Risk factors for urethral stricture and/or bladder neck contracture after monopolar transurethral resection of the prostate for benign prostatic hyperplasia. Urologia. 2018;85(4):150-157. DOI: 10.1177/0391560318758195</mixed-citation><mixed-citation xml:lang="en">Grechenkov A, Sukhanov R, Bezrukov E, Butnaru D, Barbagli G, Vasyutin I, Tivtikyan A, Rapoport L, Alyaev Y, Glybochko P. Risk factors for urethral stricture and/or bladder neck contracture after monopolar transurethral resection of the prostate for benign prostatic hyperplasia. Urologia. 2018;85(4):150-157. DOI: 10.1177/0391560318758195</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG; Urology Section of the Bavarian Working Group for Quality Assurance. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1):246-249. DOI: 10.1016/j.juro.2008.03.058</mixed-citation><mixed-citation xml:lang="en">Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG; Urology Section of the Bavarian Working Group for Quality Assurance. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1):246-249. DOI: 10.1016/j.juro.2008.03.058</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Аббосов Ш.А., Сорокин Н.И., Кадрев А.В., Шомаруфов А.Б., Нестерова О.Ю., Акилов Ф.А., Камалов А.А. Предикторы развития склероза шейки мочевого пузыря после трансуретральных вмешательств на предстательной железе. Урология. 2021;(5):73-77. DOI: 10.18565/urology.2021.5.73-77</mixed-citation><mixed-citation xml:lang="en">Abbosov S.A., Sorokin N.I., Kadrev A.V., Shomarufov A.B., Nesterova O.Y., Akilov F.A., Kamalov A.A. Predictors of bladder neck contracture after transurethral procedure on the prostate. Urologiia. 2021;(5):73-77. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Barbalias D, Lappas G, Ravazoula P, Liourdi D, Kyriazis I, Liatsikos E, Kallidonis P. Evaluation of the Distribution of Paclitaxel After Application of a Paclitaxel-Coated Balloon in the Rabbit Urethra. J Endourol. 2018;32(5):381-386. DOI: 10.1089/end.2017.0935</mixed-citation><mixed-citation xml:lang="en">Barbalias D, Lappas G, Ravazoula P, Liourdi D, Kyriazis I, Liatsikos E, Kallidonis P. Evaluation of the Distribution of Paclitaxel After Application of a Paclitaxel-Coated Balloon in the Rabbit Urethra. J Endourol. 2018;32(5):381-386. DOI: 10.1089/end.2017.0935</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Рева И.А., Живов А.В., Берников А.Н., Пушкарь Д.Ю. Факторы риска развития и методики коррекции послеоперационного стеноза везикоуретрального анастомоза (обзор литературы). Онкоурология. 2017;13(2):104-112. DOI: 10.17650/1726-9776-2017-13-2-104-112</mixed-citation><mixed-citation xml:lang="en">Reva I.A., Zhivov A.V., Bernikov A.N., Pushkar’ D.Yu. Risk factors and correction methods for postoperative vesicourethral anastomotic strictures: literature review. Cancer Urology. 2017;13(2):104-112. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Favre GA, Alfieri AG, Gil Villa SA, Tobia I, Giudice CR. Bulbomembranous Urethral Strictures Repair After Surgical Treatment of Benign Prostatic Hyperplasia. Experience From a Latin American Referral Centre. Urology. 2021;147:281-286. DOI: 10.1016/j.urology.2020.08.085</mixed-citation><mixed-citation xml:lang="en">Favre GA, Alfieri AG, Gil Villa SA, Tobia I, Giudice CR. Bulbomembranous Urethral Strictures Repair After Surgical Treatment of Benign Prostatic Hyperplasia. Experience From a Latin American Referral Centre. Urology. 2021;147:281-286. DOI: 10.1016/j.urology.2020.08.085</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Abbosov SA, Sorokin NI, Shomarufov AB, Kadrev AV, Ugli N, Khusniddin Z, Mukhtarov ST, Akilov FA, Kamalov AA. Bladder Neck Contracture as a Complication of Prostate Surgery. Alternative Treatment Methods and Prospects (Literature Review). Urological Science. 2022;33(2):49-55. DOI: 10.4103/UROS.UROS_127_21</mixed-citation><mixed-citation xml:lang="en">Abbosov SA, Sorokin NI, Shomarufov AB, Kadrev AV, Ugli N, Khusniddin Z, Mukhtarov ST, Akilov FA, Kamalov AA. Bladder Neck Contracture as a Complication of Prostate Surgery. Alternative Treatment Methods and Prospects (Literature Review). Urological Science. 2022;33(2):49-55. DOI: 10.4103/UROS.UROS_127_21</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Steenkamp JW, Heyns CF, de Kock ML. Internal urethrotomy versus dilation as treatment for male urethral strictures: a prospective, randomized comparison. J Urol. 1997;157(1):98-101. PMID: 8976225.</mixed-citation><mixed-citation xml:lang="en">Steenkamp JW, Heyns CF, de Kock ML. Internal urethrotomy versus dilation as treatment for male urethral strictures: a prospective, randomized comparison. J Urol. 1997;157(1):98-101. PMID: 8976225.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Vicente J, Salvador J, Caffaratti J. Endoscopic urethrotomy versus urethrotomy plus Nd-YAG laser in the treatment of urethral stricture. Eur Urol. 1990;18(3):166-168. DOI: 10.1159/000463901</mixed-citation><mixed-citation xml:lang="en">Vicente J, Salvador J, Caffaratti J. Endoscopic urethrotomy versus urethrotomy plus Nd-YAG laser in the treatment of urethral stricture. Eur Urol. 1990;18(3):166-168. DOI: 10.1159/000463901</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lee YH, Chiu AW, Huang JK. Comprehensive study of bladder neck contracture after transurethral resection of prostate. Urology. 2005;65(3):498-503; discussion 503. DOI: 10.1016/j.urology.2004.10.082</mixed-citation><mixed-citation xml:lang="en">Lee YH, Chiu AW, Huang JK. Comprehensive study of bladder neck contracture after transurethral resection of prostate. Urology. 2005;65(3):498-503; discussion 503. DOI: 10.1016/j.urology.2004.10.082</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Мухтаров Ш.Т., Насиров Ф.Р., Бахадирханов М.М., Уралова Н.Д., Акилов Ф.А., Мирхамидов Д.Х., Шомаруфов А.Б., Аббосов Ш.А., Касимов С.С. Оценка эффективности и безопасности эндоскопического лечения облитерации бульбарно-мембранозного отдела уретры. Вестник урологии. 2022;10(4):79-87. DOI: 10.21886/2308-6424-2022-10-4-79-87</mixed-citation><mixed-citation xml:lang="en">Mukhtarov Sh.T., Nasirov F.R., Bakhadirkhanov M.M., Uralova N.D., Akilov F.A., Mirkhamidov D.Kh., Shomarufov A.B., Abbosov Sh.A., Kasimov S.S. Endoscopic treatment for bulbar-membranous urethral obliteration: evaluation of the efficacy and safety. Urology Herald. 2022;10(4):79-87. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Abbosov ShA, Sorokin NI, Shomarufov AB, Kadrev AV, Mikheev KV, Fozilov AA, Nadjimitdinov YS, Ohobotov DA, Giyasov ShI, Mukhtarov ShT, Akilov FA, Kamalov AA. Assessment of the Balloon Dilation Efficiency in Bladder Neck Contracture after Transurethral Interventions on the Prostate. Urological Science. 2022;33(3):130-135. DOI: 10.4103/UROS.UROS_148_21</mixed-citation><mixed-citation xml:lang="en">Abbosov ShA, Sorokin NI, Shomarufov AB, Kadrev AV, Mikheev KV, Fozilov AA, Nadjimitdinov YS, Ohobotov DA, Giyasov ShI, Mukhtarov ShT, Akilov FA, Kamalov AA. Assessment of the Balloon Dilation Efficiency in Bladder Neck Contracture after Transurethral Interventions on the Prostate. Urological Science. 2022;33(3):130-135. DOI: 10.4103/UROS.UROS_148_21</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ramchandani P, Banner MP, Berlin JW, Dannenbaum MS, Wein AJ. Vesicourethral anastomotic strictures after radical prostatectomy: efficacy of transurethral balloon dilation. Radiology. 1994;193(2):345-349. DOI: 10.1148/radiology.193.2.7972741</mixed-citation><mixed-citation xml:lang="en">Ramchandani P, Banner MP, Berlin JW, Dannenbaum MS, Wein AJ. Vesicourethral anastomotic strictures after radical prostatectomy: efficacy of transurethral balloon dilation. Radiology. 1994;193(2):345-349. DOI: 10.1148/radiology.193.2.7972741</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ishii G, Naruoka T, Kasai K, Hata K, Omono H, Suzuki M, Kimura T, Egawa S. High pressure balloon dilation for vesicourethral anastomotic strictures after radical prostatectomy. BMC Urol. 2015;15:62. DOI: 10.1186/s12894-015-0059-9</mixed-citation><mixed-citation xml:lang="en">Ishii G, Naruoka T, Kasai K, Hata K, Omono H, Suzuki M, Kimura T, Egawa S. High pressure balloon dilation for vesicourethral anastomotic strictures after radical prostatectomy. BMC Urol. 2015;15:62. DOI: 10.1186/s12894-015-0059-9</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Аббосов Ш.А., Охоботов Д.А., Сорокин Н.И., Шомаруфов А.Б., Шапаров Б.М., Наджимитдинов Я.С., Мухтаров Ш.Т., Акилов Ф.А., Камалов А.А. Оценка эффективности баллонной дилатации рубцового сужения шейки мочевого пузыря после трансуретральных вмешательств на предстательной железе (предварительные результаты). Вестник урологии. 2021;9(1):5-13. DOI: 10.21886/2308-6424-2021-9-1-5-13</mixed-citation><mixed-citation xml:lang="en">Abbosov Sh.A., Okhobotov D.A., Sorokin N.I., Shomarufov A.B., Shaparov B.M., Nadzhimitdinov Ya.S., Mukhtarov Sh.T., Akilov F.A., Kamalov A.A. Balloon dilatation of cicatricial bladder neck contracture: evaluation of the efficacy after transurethral prostate interventions (preliminary results). Urology Herald. 2021;9(1):5-13. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Vyas JB, Ganpule AP, Muthu V, Sabnis RB, Desai MR. Balloon dilatation for male urethral strictures “revisited”. Urol Ann. 2013;5(4):245-248. DOI: 10.4103/0974-7796.120296</mixed-citation><mixed-citation xml:lang="en">Vyas JB, Ganpule AP, Muthu V, Sabnis RB, Desai MR. Balloon dilatation for male urethral strictures “revisited”. Urol Ann. 2013;5(4):245-248. DOI: 10.4103/0974-7796.120296</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Xie TP, Huang XB, Xu QQ, Ye HY, Yang QY, Wang XF. [Balloon dilation by B ultrasound monitoring for treatment of urethral stricture: 5 case reports]. Beijing Da Xue Xue Bao Yi Xue Ban. 2014;46(4):657-658. (In Chinese). PMID: 25131490.</mixed-citation><mixed-citation xml:lang="en">Xie TP, Huang XB, Xu QQ, Ye HY, Yang QY, Wang XF. [Balloon dilation by B ultrasound monitoring for treatment of urethral stricture: 5 case reports]. Beijing Da Xue Xue Bao Yi Xue Ban. 2014;46(4):657-658. (In Chinese). PMID: 25131490.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
